Table 1.
Gene name | Rank USP9XMut versus USP9XWT | Rank WT1 versus Ctrl siRNA | Relative rank USP9XMut versus USP9XWT | Relative rank WT1 versus Ctrl siRNA | Relative combined rank |
---|---|---|---|---|---|
CXCL8 | 27 | 1 | 0.9323 | 0.9818 | 0.9571 |
KRT17 | 51 | 16 | 0.8722 | 0.7091 | 0.7906 |
THBS1 | 12 | 32 | 0.9699 | 0.4182 | 0.6941 |
INSL4 | 155 | 13 | 0.6115 | 0.7636 | 0.6876 |
FBLN1 | 124 | 34 | 0.6892 | 0.3818 | 0.5355 |
TAGLN | 171 | 37 | 0.5714 | 0.3273 | 0.4494 |
GLIPR1 | 185 | 39 | 0.5363 | 0.2909 | 0.4136 |
MYL12A | 292 | 46 | 0.2682 | 0.1636 | 0.2159 |
HSPA5 | 359 | 47 | 0.1003 | 0.1455 | 0.1229 |
Ranked list of genes that were expressed significantly different in both experimental settings, USP9XWT versus USP9XMut cells, and control versus WT1 knockdown U2OS cells. Only genes with positive correlation between expression and USP9X phosphorylation or WT1 level, respectively, are listed.